SecBot SecBot
425 ·Filed Sep 21, 2026

IBAC

IB Acquisition Corp.
NEUTRAL
Impact 4/10
Horizonweeks Processed1mo ago SEC0001493152-26-043587
Rule 425 M&A communications
Actionable Insight • Neutral

Monitor for the actual 425 document content to assess any updates to deal terms, timeline, or regulatory status. The prior financing arrangements suggest significant future dilution risk if the deal closes.

DirectionNeutral
Confidencelow
Horizonweeks
Latest settled — T+20d ⚠ clustered
IBAC ▼ -5.57% at T+20d
NEUTRAL call -5.57% · α vs SPY -5.01% · entry $11.50 → $10.86
Next anchor: T+60d in 7w
Latest observation: T+23 -7.44% FF3 residual α
Entry = T+0 close
Sep 21, 2026
via day close
T+1d
-0.87%
call -0.87% · α -0.15%
$11.40
settled 5w ago
T+5d
-3.48%
call -3.48% · α -2.29%
$11.10
settled 4w ago
T+20d
-5.57%
call -5.57% · α -5.01%
$10.86
settled 9d ago
T+60d
Pending
in 7w

Price Chart

Loading chart...

Executive Summary

Analysis based on filing metadata only — document content was unavailable. This is a Rule 425 communication by IB Acquisition Corp. (IBAC) related to its pending business combination with GNQ Insilico Inc. The cross-filing context shows a prior 8-K announcing up to $106.47M in senior secured convertible notes and a $50M equity purchase facility, both contingent on the deal closing. The 425 likely provides additional deal details or investor materials, but without the actual document, no specific content can be assessed.

Key Financial Metrics

Deal Type
merger

Key Facts

  • Filing is a Rule 425 communication related to IBAC's business combination with GNQ Insilico Inc.
  • Prior 8-K (filed same day) disclosed up to $106.47M in senior secured convertible notes and a $50M equity purchase facility contingent on deal closing.
  • Actual 425 document content was unavailable for analysis.

Financial Impact

No financial figures available from this filing.

Risk Factors

  • Deal may fail to close, rendering financing arrangements void.
  • If deal closes, convertible notes and equity facility could cause substantial dilution for existing shareholders.
  • Regulatory or shareholder approval risks for the business combination.

Investment Themes

Traditional Finance

Documents Analyzed

Report based on filing metadata.

5 reports for IBAC
Performance horizon
100% Hit rate @ T+5 3 of 3 directional calls Went positive at some point 3 of 3 best @ T+20▲ +5.57%Sep 21, 2026
Filters
Rows
Reports for IBAC — sortable, filterable
TypeNow
Oct 15, 2026
12d ago
8-K
NEUTRAL ★ 3/10
$10.86 $10.86· 0.00%▼ −0.09%$10.86 (−0.00%)
Oct 6, 2026
21d ago
8-K
BEARISH ★ 6/10
$10.88 $10.86▲ +0.18%▼ −0.80%$10.86 (+0.18%)
Sep 23, 2026
4w ago
425
BEARISH ★ 6/10
$11.30 $10.91▲ +3.45%▲ +3.04%$10.86 (+3.89%)
Sep 21, 2026
5w ago
425
NEUTRAL ★ 4/10
$11.50 $11.10▼ −3.48%▼ −2.29%$10.86 (−5.57%)
Sep 21, 2026
5w ago
8-K
BEARISH ★ 6/10
$11.50 $11.10▲ +3.48%▲ +2.29%$10.86 (+5.57%)
Showing 5 of 5

US Market Status

Market Closed — Opens Thu (13h 20m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 21, 2026